Prioritizing Methodological Research: Presentations

Thurs 23 Sept 2010 | Fri 24 Sept 2010

Prioritizing Methodological Research in Evaluation of Health Technologies FINAL PROGRAM 


Thursday, 23 September 2010

15:00 – 15:15

Welcome and Opening Remarks

15:15 – 15:30

  • Overview of the Methodology Forum: Prioritizing Methodological Research in Evaluation of Health Technologies
    Michael Drummond, Forum Moderator; Professor of Health Economics, University of York
    Download Presentation 

15:30 – 16:00

  • Identifying NICE's Methodological Research Priorities: a survey of priorities
    Mark Sculpher, University of York
    Download Presentation 

16:00 – 16:10

  • International and Stakeholder Perspectives
    Chris Henshall, Chair, Health Technology Assessment International Policy Forum
    Download Presentation 

16:10 – 16:30

  • Discussion

16:45 – 17:45

Health Policy Panel Session

Moderator: Michael Drummond, University of York

  • Brian O'Rourke, Canadian Agency for Drugs and Technology in Health
    Robert Petersen, Chair, Canadian Expert Drug Advisory Committee and Executive Director of the Drug Safety and Effectiveness Network
    Jean Pruneau, Health Canada
    Newell McElwee, Merck
     


Friday, 24 September 2010

08:00 – 08:15

Overview of the Agenda

  • Michael Drummond, Forum Moderator; Professor of Health Economics, University of York

08:15 – 09:30

Methodological Challenge #1 - Data quality and the development of national costing panels to better utilize administrative data

Chair and Discussant: Tammy Clifford, Canadian Agency for Drugs and Technologies in Health

09:30 – 10:00

Methodological Challenge #2 - Incorporating routine measurement of patient reported outcomes

Chair and Discussant: Herb Emery, University of Calgary

  • Presenter:
  • Stirling Bryan, University of British Columbia and Vancouver Coastal Health Authority
    Download Presentation 

10:30 – 11:15

Methodological Challenge #3 - How to incorporate multi-criteria decision frameworks into economic evaluations and decision making

Chair and Discussant: Farzad Ali, Pfizer

11:15 – 11:45

Methodological Challenge #4 - Approaches to mitigating against methodologic bias in economic evaluations

Chair and Discussant: Karen Lee, Canadian Agency for Drugs and Technologies in Health

13:00 – 14:00

Methodological Challenge #5 - How to incorporate a broader health system and societal perspective in evaluation including the value of innovation

Chair and Discussant: Mark Sculpher, University of York

  • Presenters:
  • Marc Berger, Eli Lilly
    Download Presentation 
  • Don Husereau, Canadian Agency for Drugs and Technologies in Health

14:00 – 15:15

Prioritization Panel Discussion and Debate

Moderator: Michael Drummond

  • Panel Members:
    Tom Noseworthy, University of Calgary
    Kathy Kovac Burns, Health Sciences Council, University of Alberta
    Terri Jackson, University of Queensland/University of Alberta
    Nigel Rawson, GSK

15:30 – 15:45

Closing Comments and Next Steps

  • Michael Drummond, Forum Moderator; Professor of Health Economics, University of York
    Download Presentation